Antipsychotic Treatment
0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
AstraZenecaCAMBRIDGE, United Kingdom
1 programKvaliMed - a Quality Project With Focus on Patients in Antipsychotic TreatmentN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
AstraZenecaKvaliMed - a Quality Project With Focus on Patients in Antipsychotic Treatment
Clinical Trials (1)
Total enrollment: 212 patients across 1 trials
NCT00750776AstraZenecaKvaliMed - a Quality Project With Focus on Patients in Antipsychotic Treatment
KvaliMed - a Quality Project With Focus on Patients in Antipsychotic Treatment
Start: Aug 2003Est. completion: Aug 2012212 patients
N/ATerminated
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space